Stratified Dermal Bioavailability and Toxicity
The new terminus Stratified Dermal Bioavailability and Toxicity is an umbrella category focusing on topically applied products.
The concept is driven from the approach, which subdivides patients into groups based on their risk of developing specific diseases or their response to particular therapies.
In general, the discipline of Stratified Medicine is recognized as a key global priority for healthcare providers, pharmaceutical and diagnostic industries and patients.
The mission could be summarized to enable healthcare professionals to provide the “right treatment, for the right person, at the right time”. In contrast to personal medicine, not a single individual is addressed, but a specific group.
Subgrouping of population might include age or gender related differences, disease status or responses to environmental or seasonal impacts.
Bock Project Management is actively participating in R&D
In order to develop and evaluate the potential benefits of new technologies applied on the skin regarding their efficiency and safety under theses aspects, Bock Project Management is actively participating in R&D projects addressing aspects on Stratified Dermal Bioavailability and Toxicity.